OUP Management as of Dec. 31, 2021
Portfolio Holdings for OUP Management
OUP Management holds 16 positions in its portfolio as reported in the December 2021 quarterly 13F filing
| Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price |
|---|---|---|---|---|---|
| ionQ Common Stock (IONQ) | 31.2 | $69M | 4.1M | 16.70 | |
| Cyteir Therapeutics Common Stock | 12.7 | $28M | 2.5M | 11.37 | |
| Centessa Pharmaceuticals Sponsored ADS (CNTA) | 11.9 | $26M | 2.3M | 11.26 | |
| PMV Pharmaceuticals Common Stock (PMVP) | 10.3 | $23M | 989k | 23.10 | |
| DICE Therapeutics Common Stock | 6.1 | $14M | 537k | 25.31 | |
| Landos Biopharma Common Stock | 4.0 | $8.8M | 1.8M | 4.80 | |
| eFFECTOR Therapeutics Common Stock | 3.8 | $8.5M | 1.0M | 8.28 | |
| Precision BioSciences Common Stock | 3.7 | $8.3M | 1.1M | 7.40 | |
| Evolv Technologies Holdings Common Stock (EVLV) | 3.7 | $8.1M | 1.8M | 4.46 | |
| Aerovate Therapeutics Common Stock (AVTE) | 3.2 | $7.1M | 604k | 11.79 | |
| Graphite Bio Common Stock | 2.3 | $5.1M | 406k | 12.43 | |
| Sera Prognostics Common Stock (SERA) | 2.0 | $4.4M | 641k | 6.87 | |
| Vor Biopharma Common Stock (VOR) | 2.0 | $4.4M | 375k | 11.62 | |
| Spero Therapeutics Common Stock (SPRO) | 1.8 | $4.0M | 249k | 16.01 | |
| Selecta Biosciences Common Stock (RNAC) | 1.3 | $2.8M | 863k | 3.26 | |
| Homology Medicines Common Stock | 0.1 | $233k | 64k | 3.64 |
